In this article we will explore Fluproquazone, a topic that has captured the attention and interest of many people today. Fluproquazone is a topic that covers a wide range of aspects and has a significant impact on various areas of life. As we progress through this article, we will explore the different facets of Fluproquazone and examine its relevance in contemporary society. Additionally, we will dive into the different perspectives and opinions that exist around Fluproquazone, offering a complete and balanced view of this topic. Without a doubt, Fluproquazone is a topic that deserves our attention and detailed analysis, so we will delve into its complexity and depth throughout this article.
| Clinical data | |
|---|---|
| ATC code |
|
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| UNII | |
| KEGG | |
| CompTox Dashboard (EPA) | |
| Chemical and physical data | |
| Formula | C18H17FN2O |
| Molar mass | 296.345 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
| (verify) | |
Fluproquazone (trade name Tormosyl, RF 46-790 ) was a quinazolinone derivative with potent analgesic, antipyretic, and anti-inflammatory effects discovered by Sandoz.[1][2][3][4] It was withdrawn during development due to liver toxicity.[5]: 370 [6]: 520